Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors
Borazanci, E., Schram, A. M., Garralda, E., Brana, I., Vieito Villar, M., Spreafico, A., . . . Tabernero, J. (2022). … Read More